Table 2.
Characteristics of studies included only in the qualitative synthesis ND: no data.
Publication data | GR 1 | GR 2 | Design | Demography | No. of patients | Definition of clinical success | Definition of recurrence | Mean follow up (months) | ||||
---|---|---|---|---|---|---|---|---|---|---|---|---|
First author | Year of publication | Country, institution | Age (years) group surgical excision | Female ratio % Group 1 | ||||||||
Mean | Standard deviation | |||||||||||
Chaugule et al.36 | 2017 | IFN | 5-FU | Retrospective, interventional series | USA—The New York Eye Cancer Center | ND | ND | ND | 6 | Clinical resolution of the tumor, defined on slit-lamp examination | Reappearance of the lesion at a similar location, after complete resolution | IFN: 8.8; 5-FU: 18 |
Kusumesh et al.37 | 2017 | IFN | MMC | Retrospective, comparative study | Patna, India—Cornea Services, Regional Institute of Ophthalmology, Indira Gandhi Institute of Medical Sciences | 59.5 | 14.55 | ND | 51 | Total disappearance of lesions with clear visibility of underlying structures | Reappearance of a tumor at the same location or at any other location after complete resolution | IFN: 22.2 MMC: 23.6 |
Venkateswaran et al.38 | 2018 | IFN | 5-FU | Retrospective, comparative, interventional case series | USA—University of Miami, Bascom Palmer Eye Institute | 67.5 | 11 | ND | 102 | Disappearance of the lesion clinically and/or by AS-OCT | Reappearance of a tumor at the same/similar location or at any part of the ocular surface after complete resolution | 5-FU: 15.8 IFN: 20.9 |